Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Pain Med. 2012 Jul 3;13(9):1174–1180. doi: 10.1111/j.1526-4637.2012.01430.x

Table 1.

Patient self-reported characteristics for the overall sample and stratified by whether the patient had a pain medicine agreement, as reported by their primary care provider (PCP) (N(%) unless noted)

Overall
sample
PCP reported
patient had a
pain agreement
PCP reported
patient did not
have a pain
agreement
p-valuea
(N=84) (N=36) (N=48)
Age (mean (SD)) 50.3 (7.4) 51.5 (5.1) 49.3 (8.6) 0.19
Income (median (IQR)) $900 (99) $900 (110) $901 (84) 0.55
Male sex at birth 48 (57.1) 23 (63.9) 25 (52.1) 0.28
Race
 white 30 (34.9) 13 (36.1) 17 (35.4) 0.54
 African-American 43 (51.2) 20 (55.6) 23 (47.9)
 other or mixed race 11 (13.1) 3 (8.3) 8 (16.6)
Less than high school education 27 (32.5) 11 (30.6) 16 (34.0) 0.74
Pain of severe intensity b 72 (85.7) 34 (94.4) 38 (79.2) 0.06
Prescription for long-acting opioid b 49 (58.3) 20 (55.6) 29 (60.4) 0.66
Current smoker at baseline 61 (72.6) 33 (91.7) 28 (58.3) 0.001
Lifetime history of substance use disorder c 59 (72.8) 26 (72.2) 33 (73.3) 0.91
Lifetime history of alcohol use disorder d 48 (58.5) 23 (63.9) 25 (54.4) 0.38
Screener and Opioid Assessment for
Patients with Pain total score (mean (SD))
22.3 (10.0) 26.0 (9.7) 19.5 (9.3) 0.003
a

p-value from test of association between patient characteristic and whether the patient had a pain medicine agreement (reported by PCPs)

b

ever endorsed at quarterly interviews during year covered by the PCP’s report

c

n=81; DIS-IV diagnosis of abuse or dependence relating to cocaine, methamphetamine, and/or heroin/opiates

d

n=82; DIS-IV diagnosis of abuse or dependence relating to alcohol